Specialty Drugs Account for Majority of Drug Spending
In a striking shift within the pharmaceutical landscape, specialty drugs now account for more than half of total drug spending in the United States. This significant milestone underscores a growing reliance on high-cost medications required for treating complex, chronic conditions, particularly in oncology, autoimmune diseases, and rare disorders. As healthcare costs continue to escalate, stakeholders…












